Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review

• Published in: American journal of clinical dermatology 2024-09, Vol.25 (5), p.701-716
• Main Authors: Oprea, Yasmine, Antohi, Daniel R., Vague, Morgan, Delbourgo Patton, Caroline, Wu, Benedict, Ortega‐Loayza, Alex G.
• Format: Article
• Language: English
• Subjects: Acne; Arthritis; Citation management software; Dermatology; Immune system; Immunity (Disease); Literature reviews; Medicine; Medicine & Public Health; Mutation; Pathogenesis; Patients; Pharmacology/Toxicology; Pharmacotherapy; Skin diseases; Systematic Review
• ISSN: 1175-0561; 1179-1888; 1179-1888
• DOI: 10.1007/s40257-024-00875-y

Background and Objective Pyoderma gangrenosum (PG) is a rare ulcerative neutrophilic dermatosis that can be associated with primary immunodeficiency. The pathogenesis of PG has not yet been elucidated, although contributions from dysregulation of the immune system in patients with apparent genetic predispositions have been postulated. We conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-guided systematic review with the objective of identifying inborn errors of immunity in the presence of PG as well as their clinical characteristics of severity including number of PG lesions and anatomic areas affected, and treatment outcomes. Methods A literature search was performed using PubMed/MEDLINE, Embase, Cochrane Library, and Web of Science through August 24, 2023, for studies published in English using the search terms: “pyoderma gangrenosum,” “inborn error of immunity,” “immune defect*,” and a list of genetic mutations potentially associated with PG. Results Seventy-four cases of PG associated with inborn errors of immunity were identified. The results demonstrate an association of PG with a variety of inborn errors of immunity, including genetic mutations not classically associated with the condition. Genetic mutations such as BTK , IL1RN , ITGB2 , LPIN2 , MEFV , NFkB1 , NLRP3 , NLRP12 , NOD2 , PSMB8 , PLCG2 , PSTPIP1 , RAG1 , TTC37 , and WDR1 , as well as complement component 2 / complement component 4 (C2/C4) and complement component 7 (C7) deficiencies were identified in the presence of either idiopathic or syndromic PG. Of note, mutations in genes such as PSMB8 , NLRP3 , and IL1RN were found to be associated with a more severe and atypical course of PG, whereas mutations in RAG1 as well as those causing a C2/C4 deficiency were associated with the mildest clinical presentations of PG. Mutations in NFkB1 , ITGB2 , and PSTPIP1 were associated with the most heterogeneous clinical presentations. Conclusions Human inborn errors of immunity may be implicated in the genetic predisposition to PG and may influence the clinical presentation. Due to the rarity of these diseases, further work must be done to describe the association between inborn errors of immunity and PG. Identifying inborn errors of immunity that may contribute to the development of PG may assist in further elucidating the mechanism of PG, guiding targeted treatment, and improving clinical outcomes for these patients.